Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration
Терапевтическое воздействие на вызванные ожирением нейровоспаление и нейродегенерацию
2025-01-17
SCID: 54.1/6as99kw4
Discuss with AI
gut dysbiosisgut-brain axisinsulin resistanceneurodegenerationobesity-induced neuroinflammation
Figures from the paper
Abstract (AI)
Obesity is a major modifiable risk factor leading to neuroinflammation and neurodegeneration. Excessive fat storage in obesity promotes the progressive infiltration of immune cells into adipose tissue, resulting in the release of pro-inflammatory factors such as cytokines and adipokines. These inflammatory mediators circulate through the bloodstream, propagating inflammation both in the periphery and in the central nervous system. Gut dysbiosis, which results in a leaky intestinal barrier, exacerbates inflammation and plays a significant role in linking obesity to the pathogenesis of neuroinflammation and neurodegeneration through the gut-brain/gut-brain-liver axis. Inflammatory states within the brain can lead to insulin resistance, mitochondrial dysfunction, autolysosomal dysfunction, and increased oxidative stress. These disruptions impair normal neuronal function and subsequently lead to cognitive decline and motor deficits, similar to the pathologies observed in major neurodegenerative diseases, including Alzheimer's disease, multiple sclerosis, and Parkinson's disease. Understanding the underlying disease mechanisms is crucial for developing therapeutic strategies to address defects in these inflammatory and metabolic pathways. In this review, we summarize and provide insights into different therapeutic strategies, including methods to alter gut dysbiosis, lifestyle changes, dietary supplementation, as well as pharmacological agents derived from natural sources, that target obesity-induced neuroinflammation and neurodegeneration.
Key Findings
1
Gut dysbiosis and intestinal barrier dysfunction link obesity to central nervous system inflammation through the gut-brain and gut-brain-liver axes.
2
Obesity promotes neuroinflammation and neurodegeneration through immune-cell infiltration, circulating cytokines and adipokines, and systemic inflammatory signaling.
3
Obesity-associated brain inflammation induces insulin resistance, mitochondrial and autolysosomal dysfunction, and oxidative stress, impairing neuronal function.
4
Potential therapeutic strategies include modifying gut dysbiosis, lifestyle interventions, dietary supplementation, and natural-source pharmacological agents targeting inflammatory and metabolic pathways.
5
These metabolic and inflammatory disruptions contribute to cognitive decline and motor deficits resembling Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.
Research Object
obesity-induced neuroinflammation and neurodegeneration
Research Subject
therapeutic strategies targeting inflammatory and metabolic pathways underlying obesity-induced neuroinflammation and neurodegeneration
Publication Details
Publication Date
2025-01-17
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest